Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

AST-120, an Adsorbent of Uremic Toxins, Improves the Pathophysiology of Heart Failure in Conscious Dogs.

Asanuma H, Chung H, Ito S, Min KD, Ihara M, Takahama H, Funayama M, Imazu M, Fukuda H, Ogai A, Asano Y, Minamino T, Takashima S, Morita T, Sugimachi M, Asakura M, Kitakaze M.

Cardiovasc Drugs Ther. 2019 Jun;33(3):277-286. doi: 10.1007/s10557-019-06875-z.

PMID:
30903544
2.

Piwi Nuclear Localization and Its Regulatory Mechanism in Drosophila Ovarian Somatic Cells.

Yashiro R, Murota Y, Nishida KM, Yamashiro H, Fujii K, Ogai A, Yamanaka S, Negishi L, Siomi H, Siomi MC.

Cell Rep. 2018 Jun 19;23(12):3647-3657. doi: 10.1016/j.celrep.2018.05.051.

3.

Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure.

Ohara T, Hashimura K, Asakura M, Ogai A, Amaki M, Hasegawa T, Kanzaki H, Sonoda M, Nishizawa H, Funahashi T, Kitakaze M.

J Cardiol. 2011 Sep;58(2):181-90. doi: 10.1016/j.jjcc.2011.06.010. Epub 2011 Aug 6.

4.

Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure.

Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, Ogai A, Okazaki H, Asai M, Nagamachi Y, Maeda N, Shintani Y, Minamino T, Asakura M, Kishimoto I, Funahashi T, Tomoike H, Kitakaze M.

J Am Coll Cardiol. 2009 Jun 2;53(22):2070-7. doi: 10.1016/j.jacc.2009.02.038.

5.

Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase.

Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M.

Circulation. 2009 May 19;119(19):2568-77. doi: 10.1161/CIRCULATIONAHA.108.798561. Epub 2009 May 4.

PMID:
19414638
6.

Crossveinless-2 controls bone morphogenetic protein signaling during early cardiomyocyte differentiation in P19 cells.

Harada K, Ogai A, Takahashi T, Kitakaze M, Matsubara H, Oh H.

J Biol Chem. 2008 Sep 26;283(39):26705-13. doi: 10.1074/jbc.M801485200. Epub 2008 Jul 28.

7.

Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation.

Liao Y, Zhao H, Ogai A, Kato H, Asakura M, Kim J, Asanuma H, Minamino T, Takashima S, Kitakaze M.

Hypertens Res. 2008 Feb;31(2):335-44. doi: 10.1291/hypres.31.335.

PMID:
18360054
8.

Identification of p32 as a novel substrate for ATM in heart.

Kato H, Takashima S, Asano Y, Shintani Y, Yamazaki S, Seguchi O, Yamamoto H, Nakano A, Higo S, Ogai A, Minamino T, Kitakaze M, Hori M.

Biochem Biophys Res Commun. 2008 Feb 22;366(4):885-91. Epub 2007 Dec 10.

PMID:
18070599
9.

Impact of blockade of histamine H2 receptors on chronic heart failure revealed by retrospective and prospective randomized studies.

Kim J, Ogai A, Nakatani S, Hashimura K, Kanzaki H, Komamura K, Asakura M, Asanuma H, Kitamura S, Tomoike H, Kitakaze M.

J Am Coll Cardiol. 2006 Oct 3;48(7):1378-84. Epub 2006 Sep 14.

10.

Granulocyte colony-stimulating factor mediates cardioprotection against ischemia/reperfusion injury via phosphatidylinositol-3-kinase/Akt pathway in canine hearts.

Takahama H, Minamino T, Hirata A, Ogai A, Asanuma H, Fujita M, Wakeno M, Tsukamoto O, Okada K, Komamura K, Takashima S, Shinozaki Y, Mori H, Mochizuki N, Kitakaze M.

Cardiovasc Drugs Ther. 2006 Jun;20(3):159-65.

PMID:
16775664
11.

Blockade of histamine H2 receptors protects the heart against ischemia and reperfusion injury in dogs.

Asanuma H, Minamino T, Ogai A, Kim J, Asakura M, Komamura K, Sanada S, Fujita M, Hirata A, Wakeno M, Tsukamoto O, Shinozaki Y, Myoishi M, Takashima S, Tomoike H, Kitakaze M.

J Mol Cell Cardiol. 2006 May;40(5):666-74. Epub 2006 Apr 17.

PMID:
16603184
12.

Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.

Komamura K, Sasaki T, Hanatani A, Kim J, Hashimura K, Ishida Y, Ohkaru Y, Asayama K, Tanaka T, Ogai A, Nakatani T, Kitamura S, Kangawa K, Miyatake K, Kitakaze M.

Heart. 2006 May;92(5):615-8. Epub 2005 Dec 30.

13.

A role of opening of mitochondrial ATP-sensitive potassium channels in the infarct size-limiting effect of ischemic preconditioning via activation of protein kinase C in the canine heart.

Tsukamoto O, Asanuma H, Kim J, Minamino T, Takashima S, Ogai A, Hirata A, Fujita M, Shinozaki Y, Mori H, Tomoike H, Hori M, Kitakaze M.

Biochem Biophys Res Commun. 2005 Dec 23;338(3):1460-6. Epub 2005 Oct 26.

PMID:
16271703
14.

A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts.

Asanuma H, Minamino T, Sanada S, Ogita H, Kim J, Fujita M, Hirata A, Tsukamoto O, Ogai A, Node K, Hori M, Tomoike H, Kitakaze M.

J Mol Cell Cardiol. 2005 Oct;39(4):605-14.

PMID:
16087189
15.

Aldosterone nongenomically worsens ischemia via protein kinase C-dependent pathways in hypoperfused canine hearts.

Fujita M, Minamino T, Asanuma H, Sanada S, Hirata A, Wakeno M, Myoishi M, Okuda H, Ogai A, Okada K, Tsukamoto O, Koyama H, Hori M, Kitakaze M.

Hypertension. 2005 Jul;46(1):113-7. Epub 2005 Jun 13.

PMID:
15956114
16.

Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.

Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Asanuma H, Minamino T, Tomoike H, Hori M, Kitakaze M.

Cardiovasc Res. 2005 Mar 1;65(4):879-88.

PMID:
15721868
17.

Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.

Sanada S, Asanuma H, Minamino T, Node K, Takashima S, Okuda H, Shinozaki Y, Ogai A, Fujita M, Hirata A, Kim J, Asano Y, Mori H, Tomoike H, Kitamura S, Hori M, Kitakaze M.

Circulation. 2004 Oct 12;110(15):2143-9. Epub 2004 Sep 27.

PMID:
15451788
18.

Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.

Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M.

Circulation. 2004 Aug 10;110(6):692-9. Epub 2004 Jul 19.

PMID:
15262839
19.

Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C.

Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S, Fukushima T, Ogai A, Shinozaki Y, Fujita M, Hirata A, Okuda H, Shimokawa H, Tomoike H, Hori M, Kitakaze M.

Circulation. 2004 Jul 6;110(1):51-7. Epub 2004 Jun 21.

PMID:
15210595
20.

Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts.

Asanuma H, Minamino T, Sanada S, Takashima S, Ogita H, Ogai A, Asakura M, Liao Y, Asano Y, Shintani Y, Kim J, Shinozaki Y, Mori H, Node K, Kitamura S, Tomoike H, Hori M, Kitakaze M.

Circulation. 2004 Jun 8;109(22):2773-9. Epub 2004 May 17.

PMID:
15148268
21.

Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.

Asanuma H, Sanada S, Ogai A, Minamino T, Takashima S, Asakura M, Ogita H, Shinozaki Y, Mori H, Node K, Tomoike H, Hori M, Kitakaze M.

J Cardiovasc Pharmacol. 2004 Apr;43(4):574-9.

PMID:
15085069
22.

Lamr1 functional retroposon causes right ventricular dysplasia in mice.

Asano Y, Takashima S, Asakura M, Shintani Y, Liao Y, Minamino T, Asanuma H, Sanada S, Kim J, Ogai A, Fukushima T, Oikawa Y, Okazaki Y, Kaneda Y, Sato M, Miyazaki J, Kitamura S, Tomoike H, Kitakaze M, Hori M.

Nat Genet. 2004 Feb;36(2):123-30. Epub 2004 Jan 18.

PMID:
14730304
23.

A calcium channel blocker activates both ecto-5(')-nucleotidase and NO synthase in HUVEC.

Asano Y, Kim J, Ogai A, Takashima S, Shintani Y, Minamino T, Kitamura S, Tomoike H, Hori M, Kitakaze M.

Biochem Biophys Res Commun. 2003 Nov 21;311(3):625-8.

PMID:
14623316
24.

Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.

Liao Y, Takashima S, Asano Y, Asakura M, Ogai A, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Ogita H, Tomoike H, Hori M, Kitakaze M.

Circ Res. 2003 Oct 17;93(8):759-66. Epub 2003 Sep 11.

PMID:
12970111
25.

Long-acting Ca2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats.

Sanada S, Node K, Minamino T, Takashima S, Ogai A, Asanuma H, Ogita H, Liao Y, Asakura M, Kim J, Hori M, Kitakaze M.

Hypertension. 2003 Apr;41(4):963-7. Epub 2003 Mar 10.

PMID:
12629037
26.

Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase.

Sanada S, Node K, Asanuma H, Ogita H, Takashima S, Minamino T, Asakura M, Liao Y, Ogai A, Kim J, Hori M, Kitakaze M.

J Am Coll Cardiol. 2002 Sep 4;40(5):991-7.

27.

Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.

Sanada S, Kitakaze M, Node K, Takashima S, Ogai A, Asanuma H, Sakata Y, Asakura M, Ogita H, Liao Y, Fukushima T, Yamada J, Minamino T, Kuzuya T, Hori M.

Hypertension. 2001 Sep;38(3):404-11.

PMID:
11566913
28.

Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.

Sanada S, Kitakaze M, Papst PJ, Asanuma H, Node K, Takashima S, Asakura M, Ogita H, Liao Y, Sakata Y, Ogai A, Fukushima T, Yamada J, Shinozaki Y, Kuzuya T, Mori H, Terada N, Hori M.

Circulation. 2001 Aug 7;104(6):705-10.

PMID:
11489779
29.

Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.

Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, Hori M.

Circ Res. 2001 Feb 2;88(2):175-80.

PMID:
11157669
30.

Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats.

Minamino T, Kitakaze M, Papst PJ, Ueda Y, Sakata Y, Asanuma H, Ogai A, Kuzuya T, Terada N, Hori M.

Cardiovasc Drugs Ther. 2000 Oct;14(5):533-42.

PMID:
11101202
31.

Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.

Korzekwa KR, Krishnamachary N, Shou M, Ogai A, Parise RA, Rettie AE, Gonzalez FJ, Tracy TS.

Biochemistry. 1998 Mar 24;37(12):4137-47.

PMID:
9521735
32.

Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein.

Matsumine A, Ogai A, Senda T, Okumura N, Satoh K, Baeg GH, Kawahara T, Kobayashi S, Okada M, Toyoshima K, Akiyama T.

Science. 1996 May 17;272(5264):1020-3.

PMID:
8638125

Supplemental Content

Support Center